Health Welldoc Expands AI-Powered Cardiometabolic Platform to Include Chronic Kidney Disease and MASH SupportHealthradar21. Oktober 2025 The AI-powered platform elevates cardiometabolic care by extending its best-in-class weight management support to CKD and MASH. COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®,…
Health Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic MarketHealthradar22. September 2025 What You Should Know: – Pfizer Inc. and Metsera, Inc. have entered into a definitive agreement under which Pfizer will…
